ESPE Abstracts

ESPE Abstracts

Published by BioScientifica
Previous issue | Volume 86 | ESPE2016 | Next issue

55th Annual ESPE (ESPE 2016)

Paris, France
10 Sept 2016 - 12 Sept 2016

Card image cap
Paris, France: 10-12 September 2016 Further information

Poster Presentations

Growth P1

Previous section
Perinatal Endocrinology P2
Table of contents
Next section
Growth P2

hrp0086p1-p593 | Growth P1

The Mechanistic Role of Fibroblast Growth Factor 21 (FGF21) in Growth Hormone Resistance Secondary to Chronic Childhood Conditions

hrp0086p1-p594 | Growth P1

Somapacitan, a Once-Weekly Reversible Albumin-Binding Growth Hormone (GH) Derivative, Is Well Tolerated and Convenient in Adults with GH Deficiency (AGHD): Results from a 26-Week Randomised, Controlled Phase 3 Trial

hrp0086p1-p595 | Growth P1

The Diagnostic Value of IGF-II, IGF-I and IGFBP-3 in Silver–Russell Syndrome

hrp0086p1-p596 | Growth P1

Functional in vitro Characterization of Two Novel Germinal STAT3 Mutations Associated with Short Stature, Immunodeficiency and Autoimmune Disease

hrp0086p1-p597 | Growth P1

Abstract unavailable

hrp0086p1-p598 | Growth P1

Human Phase1 Clinical Data of ALT-P1 (hGH-NexP) by Healthy Korean Males

hrp0086p1-p599 | Growth P1

Validation of Prediction Models for Near Final Adult Height in Children with Idiopathic Growth Hormone Deficiency Treated with Growth Hormone for 1 Year

hrp0086p1-p600 | Growth P1

The Influence of Recombinant Human Growth Hormone Treatment on Very Small Embryonic/Epiblast Like Stem Cells

hrp0086p1-p601 | Growth P1

A Lipid-Based System for the Oral Delivery of Growth Hormone

hrp0086p1-p602 | Growth P1

Prediction of First Year Response to Growth Hormone Treatment in Neural Network Models

hrp0086p1-p603 | Growth P1

Pediatric Phase 2 Data Demonstrate that TransCon hGH Has an Anti-hGH Immunogenic Profile that is Comparable to Daily hGH

hrp0086p1-p604 | Growth P1

The Exon3-Deleted Growth Hormone Receptor Gene Polymorphism (d3-GHR) is Associated with Increased Spontaneous Growth and Impaired Insulin Sensitivity in Prepubertal Short SGA Children (NESGAS)

hrp0086p1-p605 | Growth P1

A New Case of Intragenic Deletion in IGF1R with Very Mild Phenotype

hrp0086p1-p606 | Growth P1

The Role of IGF-1R Gene Polymorphisms with Regard to Susceptibility to Idiopathic Short Stature Risk in the Chinese Population of Jiangxi Area

hrp0086p1-p607 | Growth P1

Effects of the Addition of Metformin to Recombinant Human GH on Bone Maturation and Pubertal Progression in Short Children Born Small-for-Gestational-Age

hrp0086p1-p608 | Growth P1

Pubertal Height Gain in Females with Isolated Growth Hormone Deficiency Treated with rhGH Alone or in Combination with GnRHan

hrp0086p1-p609 | Growth P1

Cognitive Abilities and Academic Achievement Among Youths with Short Stature Receiving Growth Hormone Therapy

hrp0086p1-p610 | Growth P1

One Year Use of Anastrazole Improves the Predicted Adult Height of Male Adolescents with and without Associated GH Therapy

hrp0086p1-p611 | Growth P1

IGFALS Gene Deletion in a Family with Short Stature

hrp0086p1-p612 | Growth P1

Adherence with Twice-Monthly, At-Home Dosing Schedule of Somavaratan (VRS-317) Long-Acting Growth Hormone Treatment in Children with Growth Hormone Deficiency (GHD) (NCT02068521)

hrp0086p1-p613 | Growth P1

Glucose Dysregulation in Children with Growth Hormone Deficiency (GHD), Turner Syndrome (TS) or Born Small for Gestational Age (SGA) Treated with GH: A Report from the NordiNet International Outcome Study (IOS)

hrp0086p1-p614 | Growth P1

Serum α-Klotho Levels are not Informative for the Evaluation of GH Secretion in Short Children

hrp0086p1-p615 | Growth P1

Immunogenicity Results of Once-Weekly Administration of CTP-Modified Human Growth Hormone (MOD-4023): A Phase 2 Study in Children with Growth Hormone Deficiency

hrp0086p1-p616 | Growth P1

Serum IGF-I, IGFBP-3 and Als Concentrations and Physical Performance in Young Swimers During a Training Season

hrp0086p1-p617 | Growth P1

The Blood Antioxidant System in Adult Growth Hormone Deficient Patients after Concluded Childhood Growth Hormone Therapy

hrp0086p1-p618 | Growth P1

Design and Clinical Development of TransCon Growth Hormone for Growth Hormone Deficiency (GHD)

hrp0086p1-p619 | Growth P1

Mutations in PROP1 Gene in Combination with 47,XYY Karyotype: Case Report

hrp0086p1-p620 | Growth P1

Efficacy of Growth Hormone Treatment in Patients with Type 1 Diabetes Mellitus and Growth Hormone Deficiency

hrp0086p1-p621 | Growth P1

Final Height after Growth Hormone Treatment in Children with Chronic Renal Failure

hrp0086p1-p622 | Growth P1

Major Plasma Carotenoids Levels in Growth Hormone Deficient Children

hrp0086p1-p623 | Growth P1

Autosomal Dominant Growth Hormone Deficiency due to a Novel Mutation in the gh1 Gene

hrp0086p1-p624 | Growth P1

A Novel GH1 Mutation in a Family with Autosomal-Dominant Type II Isolated Growth Hormone Deficiency

hrp0086p1-p625 | Growth P1

2nd Year Pharmacokinetic and Pharmacodynamic Modeling of Long-Acting Human Growth Hormone (MOD 4023) in Growth Hormone Deficient Children

hrp0086p1-p626 | Growth P1

Significance of IGF-I Generation Test in Diagnosing Primary and Non-Primary IGF-I Deficiency – Clinical Considerations

hrp0086p1-p627 | Growth P1

Change of Growth Pattern and Thickness of Epiphyseal Plate in Female Rats According to Injected Estrogen Dosage

hrp0086p1-p628 | Growth P1

Height Gain and Safety Outcomes in Growth Hormone (GH)-Treated Girls and Boys with Idiopathic Short Stature (ISS): Experience from the Prospective GeNeSIS Observational Study

hrp0086p1-p629 | Growth P1

Treatment of Resistant Paediatric Somatotropinomas due to AIP Mutation with Pegvisomant

hrp0086p1-p630 | Growth P1

GH-Pattern with High Trophs are Often Found after Daily sc rhGH-Injection in Children

hrp0086p1-p631 | Growth P1

Are the GH Treatment Doses in Use within Secretion Rates of Healthy Children?

hrp0086p1-p632 | Growth P1

The Influence of Growth Hormone Treatment on Fat-free Mass in Prepubertal Children with Kabuki Syndrome

hrp0086p1-p633 | Growth P1

Evaluation of Prepubertal Patients with Suspected Neurosecretory Dysfunction of Growth Hormone Secretion: Diagnostic Steps and Treatment Response

hrp0086p1-p634 | Growth P1

Four-Year Results from PATRO Children, a Multi-Centre, Non-Interventional Study of the Long-Term Safety and Efficacy of Omnitrope® in Children Requiring Growth Hormone Treatment

hrp0086p1-p635 | Growth P1

Glucagon vs Clonidine Stimulation for Testing Growth Hormone Secretion in Children and Adolescents: Which is Better?

hrp0086p1-p636 | Growth P1

The Use of Tissue Doppler Imaging in Assessing Right and Left Ventricle Diastolic Function in Children with Growth Hormone Deficiency before and after 1-Year Therapy with Growth Hormone

hrp0086p1-p637 | Growth P1

Diagnosing GH Deficiency in Children by Arginine Hydrochloride Infusion Test: Relationship between Auxiological Characteristics, Arginine Plasma Profile and Arginine-Stimulated GH Release

hrp0086p1-p638 | Growth P1

Retrospective Analysis of Growth Hormone (GH) Treatment Results in Children with Idiopathic Growth Hormone Deficiency (IGHD), Turner Syndrome (TS) and Small for Gestational Age (SGA) using iGRO* in a Pediatric Endocrine Practice

hrp0086p1-p639 | Growth P1

Spanish ECOS Study Analysis: Socioeconomic Data, Adherence and Growth Outcomes with Case Studies

hrp0086p1-p640 | Growth P1

Analysis of Correlation between Stem Cells (CD133+/CD45+ and CD133+/CD45−) and Anthropometric Parameters of Children with Growth Hormone/Primary Insulin-Like Growth Factor 1 Deficiency

Published by BioScientifica

ESPE Abstracts

© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more